Retrospective analysis of the impact of interruptions in radiation therapy on long term treatment outcomes for prostate adenocarcinoma

Authors

  • Katsiaryna V. Hancharova N. N. Alexandrov National Cancer Centre of Belarus https://orcid.org/0000-0003-4383-2360 (unauthenticated)
  • Anatoly N. Batyan International Sakharov Environmental Institute, Belarusian State University
  • Pavel D. Demeshko N. N. Alexandrov National Cancer Centre of Belarus
  • Tatsiana A. Damashnikava Brest Regional Oncological Dispensary

Keywords:

radiation therapy, prostate adenocarcinoma, treatment interruptions, cancer-specific survival

Abstract

The aim of the study was to analyze cancer-specific survival in patients who completed a course of radical radiotherapy for prostate adenocarcinoma, taking into account the duration of treatment interruptions as well as factors such as age, Gleason score, and PSA level. The retrospective study included data from 360 patients who underwent radiotherapy at the N.N. Alexandrov National Cancer Centre and the Brest Regional Oncology Dispensary (2008–2016). The median follow-up period was 60 months, and statistical analysis was conducted using Cox regression and Kaplan-Meier methods. The duration of treatment interruptions and the Gleason score had prognostic significance for cancer-specific survival (p < 0.05). Among patients with low and intermediate recurrence risk, interruptions of less than or more than 3 weeks did not affect survival (89,2 % versus 92,5 %, ρlogrank = 0,612). However, in high and very high-risk groups, the study demonstrated a significant impact of radiotherapy interruptions on patient survival (96,1 % versus 89,1 %, ρlogrank = 0,026). The obtained results emphasize the importance of strict adherence to radiation therapy schedules, especially for patients at high risk of disease recurrence. An individualized treatment approach, the use of modern radiation therapy techniques such as IMRT and VMAT, as well as compensation for treatment interruptions, may contribute to improved long-term clinical outcomes.

Author Biographies

  • Katsiaryna V. Hancharova, N. N. Alexandrov National Cancer Centre of Belarus

    junior research at the laboratory of radiation therapy.

  • Anatoly N. Batyan, International Sakharov Environmental Institute, Belarusian State University

    doctor of science (medicine), full professor; head of the department of environmental medicine and radiobiology.

  • Pavel D. Demeshko, N. N. Alexandrov National Cancer Centre of Belarus

    doctor of science (medicine), full professor; chief researcher at the laboratory of radiation therapy.

  • Tatsiana A. Damashnikava, Brest Regional Oncological Dispensary

    radiation oncologist.

References

  1. The timely delivery of radical radiotherapy: guidelines for the management of unscheduled treatment interruptions, 4th edition. London: The Royal College of Radiologists; 2019. 39 p.
  2. Perez CA, Michalski J, Mansur D, et al. Impact of elapsed treatment time on outcome of external-beam radiation therapy for localized carcinoma of the prostate. Cancer. 2004;10(6):349–356.
  3. Haustermans K, Hofland I, Poppel HV, et al. Cell kinetic measurements in prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 1997;37(5):1067–1070.
  4. Lai PP, Pilepich MV, Krall JM, et al. The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 experience. International Journal of Radiation Oncology, Biology, Physics. 1991;21(4):925–933.
  5. Quantitative analysis of normal tissue effects in the clinic (QUANTEC). Review on the tolerance of normal tissue to therapeutic radiation. International Journal of Radiation Oncology, Biology, Physics. 2010;76(3):S1–S120.
  6. Algoritmy diagnostiki i lecheniya zlokachestvennykh novoobrazovaniy: klinicheskiy protokol [Algorithms for diagnosis and treatment of malignant neoplasms: clinical protocol]. Minsk: Professional publications; 2019. 616 p. Russian.
  7. Dziameshka PD, Krasny SA, Leusik EA. Luchediagnostika i luchevaya terapiya raka predstatel’noy zhelezy [Radiation diagnosis and radiotherapy of prostate cancer]. Minsk: Biznesofset; 2016. 160 p. Russian.
  8. Thames HD, Kuban D, Levy LB, et al. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiotherapy and Oncology. 2010;96:6–12.
  9. Miralbell R, Roberts SA, Zubizarreta E, et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: α/β = 1.4 (0.9–2.2) Gy. International Journal of Radiation Oncology, Biology, Physics. 2012;82(1):e17–24.
  10. Pedicini P, Strigari L, Benassi M. Estimation of a self-consistent set of radiobiological parameters from hypofractionated versus standard radiation therapy of prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 2013;85(5):e231–237.
  11. Batyan A, Dziameshka P, Hancharova K, Lemiasheuski V, Orgish A. Linear Quadratic Model in the Clinical Practice via the Web- Application [Internet, cited 2025 January 24]. Radiation Therapy. IntechOpen. 2023. 146 p. Available from: http://dx.doi.org/10.5772/ intechopen.10962112.
  12. Batyan AN, Hancharova KV, Haida AV, et al. Veb-prilozheniye issledovaniya effektivnosti doz izlucheniya pri izmenenii grafika luchevogo lecheniya [Web Application for Studying the Effectiveness of Radiation Doses with modified Radiotherapy Schedules]. Healthcare (Minsk). 2024;2(923):45–52.
  13. Batyan AN, Hancharova KV, Dziameshka PD. Utilizing the linear-quadratic model for optimizing radiation therapy in clinical practice through a web application. In: Actual environmental problems. Proceedings of the XVI International Scientific Conference of young scientists, graduates, master and PhD students, 2024 December 5–6. Minsk: [publisher unknown]; 2023. p. 82–83.

Downloads

Published

2025-04-16

How to Cite

[1]
Hancharova, K. et al. 2025. Retrospective analysis of the impact of interruptions in radiation therapy on long term treatment outcomes for prostate adenocarcinoma. Journal of the Belarusian State University. Ecology. 1 (Apr. 2025), 48–55.